US 12,716,059 · Application 17/930,965 · Granted Aug 25, 2026
US 12,716,059
Immobilized proteases for activation of the zymogen form of transglutaminase
Estimated expiration
November 3, 2043
17y 31d remaining
Earliest effective filing
Sep 9, 2022
+ 20 years
Sep 9, 2042
PTA +420d
Nov 3, 2043
No TD
—
Final
Nov 3, 2043
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- September 9, 2022
- Earliest effective filing
- September 9, 2022
- Issue date
- August 25, 2026
- PTA
- +420 days
- Base expiry (before PTA)
- September 9, 2042
September 9, 2022 + 20 years = September 9, 2042 + 420 PTA days = November 3, 2043
Continuity chain
No continuity chain; the patent’s own filing date was used.
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/930,965 · US 12,716,059
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,716,059: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12716059Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.